These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 2552912)
1. Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir. Coen DM; Goldstein DJ; Weller SK Antimicrob Agents Chemother; 1989 Aug; 33(8):1395-9. PubMed ID: 2552912 [TBL] [Abstract][Full Text] [Related]
2. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir. Spector T; Harrington JA; Morrison RW; Lambe CU; Nelson DJ; Averett DR; Biron K; Furman PA Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1051-5. PubMed ID: 2536930 [TBL] [Abstract][Full Text] [Related]
3. Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir. Spector T; Lobe DC; Ellis MN; Blumenkopf TA; Szczech GM Antimicrob Agents Chemother; 1992 May; 36(5):934-7. PubMed ID: 1324641 [TBL] [Abstract][Full Text] [Related]
4. Single mutations at many sites within the DNA polymerase locus of herpes simplex viruses can confer hypersensitivity to aphidicolin and resistance to phosphonoacetic acid. Honess RW; Purifoy DJ; Young D; Gopal R; Cammack N; O'Hare P J Gen Virol; 1984 Jan; 65 ( Pt 1)():1-17. PubMed ID: 6319564 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility of a herpes simplex virus ribonucleotide reductase null mutant to deoxyribonucleosides and antiviral nucleoside analogs. Yamada Y; Yamamoto N; Daikoku T; Nishiyama Y Microbiol Immunol; 1991; 35(8):681-6. PubMed ID: 1661366 [TBL] [Abstract][Full Text] [Related]
6. Aphidicolin resistance in herpes simplex virus type 1 appears to alter substrate specificity in the DNA polymerase. Hall JD; Woodward S J Virol; 1989 Jun; 63(6):2874-6. PubMed ID: 2542598 [TBL] [Abstract][Full Text] [Related]
7. Effects of ribonucleotide reductase inhibition on pyrimidine deoxynucleotide metabolism in acyclovir-treated cells infected with herpes simplex virus type 1. Karlsson A; Harmenberg J Antimicrob Agents Chemother; 1988 Jul; 32(7):1100-2. PubMed ID: 2847642 [TBL] [Abstract][Full Text] [Related]
8. Topical treatment of infection with acyclovir-resistant mucocutaneous herpes simplex virus with the ribonucleotide reductase inhibitor 348U87 in combination with acyclovir. Safrin S; Schacker T; Delehanty J; Hill E; Corey L Antimicrob Agents Chemother; 1993 May; 37(5):975-9. PubMed ID: 8390815 [TBL] [Abstract][Full Text] [Related]
9. Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition. Spector T; Averett DR; Nelson DJ; Lambe CU; Morrison RW; St Clair MH; Furman PA Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4254-7. PubMed ID: 2987969 [TBL] [Abstract][Full Text] [Related]
10. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome. Birch CJ; Tachedjian G; Doherty RR; Hayes K; Gust ID J Infect Dis; 1990 Sep; 162(3):731-4. PubMed ID: 2167340 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of ribonucleotide reductases encoded by herpes simplex viruses. Spector T Pharmacol Ther; 1985; 31(3):295-302. PubMed ID: 3035588 [No Abstract] [Full Text] [Related]
12. Ribonucleotide reductase: an important enzyme in the replication of herpes simplex virus type 1 and a target for antiviral chemotherapy. Prichard MN; Shipman C Chemotherapy; 1995; 41(5):384-95. PubMed ID: 8521741 [TBL] [Abstract][Full Text] [Related]
13. Aphidicolin resistance in herpes simplex virus type I reveals features of the DNA polymerase dNTP binding site. Hall JD; Wang YS; Pierpont J; Berlin MS; Rundlett SE; Woodward S Nucleic Acids Res; 1989 Nov; 17(22):9231-44. PubMed ID: 2555788 [TBL] [Abstract][Full Text] [Related]
14. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus. Coen DM; Fleming HE; Leslie LK; Retondo MJ J Virol; 1985 Feb; 53(2):477-88. PubMed ID: 2982032 [TBL] [Abstract][Full Text] [Related]
15. Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir. Larder BA; Darby G Antimicrob Agents Chemother; 1986 May; 29(5):894-8. PubMed ID: 3015009 [TBL] [Abstract][Full Text] [Related]
16. Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir. Shiraki K; Tan L; Daikoku T; Takemoto M; Sato N; Yoshida Y Antiviral Res; 2020 Aug; 180():104829. PubMed ID: 32569704 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of herpes simplex virus ribonucleotide reductase by synthetic nonapeptides: a potential antiviral therapy. Liuzzi M; Scouten E; Ingemarson R Adv Exp Med Biol; 1992; 312():129-38. PubMed ID: 1325100 [No Abstract] [Full Text] [Related]
18. Mutually exclusive inhibition of herpesvirus DNA polymerase by aphidicolin, phosphonoformate, and acyclic nucleoside triphosphates. Frank KB; Cheng YC Antimicrob Agents Chemother; 1985 Apr; 27(4):445-8. PubMed ID: 2988429 [TBL] [Abstract][Full Text] [Related]